Mucosal vaccine adjuvants containing bacterial flegellins as an active component

The present invention relates to mucosal vaccine adjuvants containing flagellins, the structural component of flagella, originated from Vibrio vulnificus, Salmonella typhimurium, and Listeria monocytogenes as an active component.

Saved in:
Bibliographic Details
Main Author RHEE JOON HAENG,LEE SHEE EUN,KIM SOO YOUNG
Format Patent
LanguageEnglish
Published 07.02.2007
Subjects
Online AccessGet full text

Cover

Loading…